E N D
1. Pandemic Influenza Task Force Infectious Disease Society of America Andrew T. Pavia M.D.
University of Utah
2. Background IDSA identified several key public policy priorities for action
Based on importance, potential role of IDSA in bringing stakeholders together and influencing policy
Antimicrobial Availability Task Force
Pandemic Influenza Task Force
4. Bad Bugs, No Drugs Targets
Scientific and medical community
Industry
Public
Policymakers
Premise: Crisis is here, responses must be initiated now.
Lays out menu of specific remedies
5. Recommendations in Bad Bugs, No Drugs Recommendations for Congress
Recommendations for FDA
Recommendations for NIAID
New funding needed
6. IDSA LeadershipWalter Stamm, PresidentKathryn Edwards, TreasurerPandemic Influenza Task Force David Fedson
Haute Savoie, France
Edward Janoff
Univ of Minnesota
Fred Hayden
Univ of Virginia Kathleen Neuzil
Univ of Washington
Andrew Pavia (chair)
Univ of Utah
Gregory Poland
Mayo Clinic
7. Actions to date Consultation with CDC, NIH
Comments on the draft Pandemic Influenza Plan
Education of the Public
Media outreach
Education of the Membership
Symposium at 2005 annual meeting
H2N2 mass email
8. Actions – ContinuedFormulation of Priorities 1. Develop vaccine and antiviral supplies and establish a nation-wide tracking system
2. Strengthen liability protections during a declared emergency
3. Vaccination programs for health care workers
9. Actions – ContinuedFormulation of Priorities 4. Improve education efforts
5. Financial Incentive to spur vaccine and antiviral R & D
6. Strengthen agency responses
7. Improve coordination and planning
10. 1. Develop vaccine and antiviral supplies and establish a nation-wide tracking system Establish dedicated supplies of vaccine and antivirals for rapid response.
Authorize and appropriate sufficient funds to establish an antiviral stockpile with sufficient drugs to treat 50% of the US population.
Develop a coordinated plan for allocation and distribution of vaccine and antivirals.
Ensure proper distribution, and if necessary, redistribuition with real-time tracking.
Maintain and strengthen surveillance of vaccine efficacy, distribution, uptake and impact.
11. Worked on specific proposals for bills
Lieberman, Hatch, Cubin, Frist
Met with members regarding upcoming legislation
Frist
Hatch
Clinton
Matheson Actions – ContinuedLegislative outreach